Dicerna Pharmaceuticals (DRNA) P/FCF US GAAP (year values) |
||||||||
2016 | 2017 | 2018 | 2019 | 2020 | LTM ? | |||
P/FCF | -1.21 | -4.12 | 33.1 | -214.1 | 10.0 | 344.9 | ||
Changes by years, y/y, % | -75% | +239% | -905% | -746% | -105% |
Dicerna Pharmaceuticals. P/FCF
Dicerna Pharmaceuticals. P/FCF, changes, %
Dicerna Pharmaceuticals (DRNA) P/FCF US GAAP (quarter values) |
||||||||
2020Q3 | 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | LTM ? | |||
P/FCF | 6.74 | 10.0 | -10.5 | 256.4 | 183.2 | 344.9 | ||
Changes by years, y/y, % | -52% | -105% | -289% | +2 991% | +2 618% | |||
Changes by quarters, q/q, % | -19% | +49% | -204% | -2 551% | -29% |